Eagle Pharmaceuticals to Present at November Conferences
Public Company Information:
WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) announced today that Scott Tarriff, President and Chief Executive Officer, and David Riggs, Chief Financial Officer, will each present at two conferences in November as follows:
|Stifel 2015 Healthcare Conference|
|Date:||Tuesday, November 17, 2015|
|Time:||9:30 a.m. EST|
|Location:||New York Palace, NYC|
Jefferies Autumn 2015 Global Healthcare Conference
|Date:||Thursday, November 19, 2015|
|Time:||8:40 a.m. GMT|
|Location:||The May Fair Hotel, London|
Each presentation will be webcast live at the aforementioned times, and archived for 90 days thereafter, via the company’s website at www.eagleus.com, under the Investors Section.
About Eagle Pharmaceuticals, Inc.
Eagle is a specialty pharmaceutical company focused on developing and commercializing injectable products that address the shortcomings, as identified by physicians, pharmacists and other stakeholders, of existing commercially successful injectable products. Eagle’s strategy is to utilize the FDA's 505(b)(2) regulatory pathway. Additional information is available on the company’s website at www.eagleus.com.